Browse drugs

…time series analysis (ITSA) to evaluate the policy’s impacts on insulin procurement prices, volumes and expenditure. Quarterly data for…

… to cure NG strains (ie, ciprofloxacin/azithromycin/ceftriaxone/cefixime) and an antimicrobial negative control that does not cure NG st…

…scarnet, cidofovir, or immunotherapies. New treatments, such as maribavir, have shown promise for refractory cases. This report discusses…

…cation from approximately 100 enrolled participants. Collecting CFM for themselves, the unused medication rate was 15%, compared wi…

…ted prescribers with education on PPI prescribing, recommending lansoprazole or omeprazole tablets/capsules where suitable. For patients not…

…0 mg daily) for 36–52 weeks (induction) followed by 12 weeks of PegIFN-α2a (180 µg weekly) add-on. The primary endpoint was the proportion…

…greater odds of perceiving ZYN as less harmful than cigarettes. ZYN with 3 mg nicotine and the ‘tobacco-free nicotine’ label were a…

…Background/objective To reduce the risk of hydroxychloroquine (HCQ)-induced retinopathy, the American Academy of Ophthalmolog…

…nificant difference in mean bodyweight was found between groups.Nivolumab was administered to 108 patients: 64 (weight 62.29 ± 32.06kg) r…

…ycin vials to capsules for second-line treatment; the rest used fidaxomicin. At the end, 100% of the CDI cases resolved.Conclusion and Rele…

…ns (3.6%), 20 irinotecan (2.0%), 196 paclitaxel (16.6%), and 21 trastuzumab (3.1%).Conclusion and Relevance A simulation analysis of a dose…

…nd lymph node (9%). In metastatic disease, 40 patients received gemcitabine-nabpaclitaxel as first-line treatment. Seventy-two percent of patients receiv…